Evolution of First-Line Immune Checkpoint Inhibition in Advanced or Metastatic Solid Tumors

home / precision-medicine-perspectives / evolution-of-first-line-immune-checkpoint-inhibition-in-advanced-or-metastatic-solid-tumors

This digital series explores the evolving first-line treatment landscape of advanced or metastatic solid tumors, including non-small cell lung cancer, with an emphasis on the use of immune checkpoint inhibitors alone or in combination with other treatment modalities.